MoneyWorks4Me

A fair growth of 14.38% in the revenue at Rs. 911.41 millions was reported in the December 2023 quarter as compared to Rs. 796.82 millions during year-ago period.The Company has registered profit of Rs. 191.20  millions for the quarter ended December 2023, a growth of 14.93%  over Rs. 166.36 millions millions achieved in the corresponding quarter of last year.OP of the company witnessed a marginal growth to 281.12 millions from 249.45 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 911.41 796.82 14.38 2730.66 2289.69 19.26 3115.29 2727.98 14.20
Other Income 35.65 37.53 -5.01 555.99 69.98 694.50 98.08 90.80 8.02
PBIDT 281.12 249.45 12.70 1315.41 586.04 124.46 846.96 817.28 3.63
Interest 0.41 0.24 70.83 1.09 0.78 39.74 1.35 0.95 42.11
PBDT 280.71 249.21 12.64 1314.32 585.26 124.57 845.61 816.33 3.59
Depreciation 27.15 26.10 4.02 78.31 75.26 4.05 102.83 95.61 7.55
PBT 253.56 223.11 13.65 1236.01 510.00 142.35 742.78 720.72 3.06
TAX 62.36 56.75 9.89 186.16 129.70 43.53 187.51 175.61 6.78
Deferred Tax -4.99 -0.24 1979.17 -7.99 -0.55 1352.73 4.97 -4.56 -208.99
PAT 191.20 166.36 14.93 1049.85 380.30 176.06 555.27 545.11 1.86
Equity 223.65 223.64 0.00 223.65 223.64 0.00 223.65 223.60 0.02
PBIDTM(%) 30.84 31.31 -1.47 48.17 25.59 88.21 27.19 29.96 -9.25
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..